Literature DB >> 9453640

Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs.

S Lukomski1, E H Burns, P R Wyde, A Podbielski, J Rurangirwa, D K Moore-Poveda, J M Musser.   

Abstract

Streptococcal pyrogenic exotoxin B (SpeB), a conserved cysteine protease expressed by virtually all Streptococcus pyogenes strains, has recently been shown to be an important virulence factor (S. Lukomski, S. Sreevatsan, C. Amberg, W. Reichardt, M. Woischnik, A. Podbielski, and J. M. Musser, J. Clin. Invest. 99:2574-2580, 1997). Genetic inactivation of SpeB significantly decreased the lethality of a serotype M49 strain for mice and abolished the lethality of a serotype M3 strain after intraperitoneal (i.p.) injection. In the present study, a wild-type M3 isolate and an M3 speB mutant derivative were used to investigate the mechanism responsible for altered virulence. Following i.p. injection, the mutant and wild-type strains induced virtually identical cellular inflammatory responses, characterized largely by an influx of polymorphonuclear leukocytes (PMNs). In addition, the mutant and wild-type strains rapidly entered the blood and were recovered from all organs examined. However, significantly fewer (P < 0.05) CFUs of the isogenic mutant derivative than of the wild-type parent strain were recovered from blood and organs. PMNs effectively cleared the M3 speB mutant from the peritoneum by 22 h, thereby sparing the host. In contrast, the wild-type M3 strain continued to replicate intraperitoneally and had the ability to kill phagocytes. This process allowed the wild-type strain to continuously disseminate, resulting in host death. Our results indicate that genetic inactivation of the cysteine protease decreased the resistance of the mutant to phagocytosis and impaired its subsequent dissemination to organs. These results provide insight into the detrimental effect of SpeB inactivation on virulence.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9453640      PMCID: PMC107969     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Counting actively metabolizing tissue cultured cells.

Authors:  H J PHILLIPS; J E TERRYBERRY
Journal:  Exp Cell Res       Date:  1957-10       Impact factor: 3.905

2.  Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection.

Authors:  H M Schrager; J G Rheinwald; M R Wessels
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

3.  Assessment of blood leukocyte microbial killing by using a new fluorochrome microassay.

Authors:  C G Pantazis; W T Kniker
Journal:  J Reticuloendothel Soc       Date:  1979-08

4.  Mechanism of action of the group A streptococcal C5a inactivator.

Authors:  D E Wexler; D E Chenoweth; P P Cleary
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

5.  Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains.

Authors:  S Lukomski; S Sreevatsan; C Amberg; W Reichardt; M Woischnik; A Podbielski; J M Musser
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

6.  Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes.

Authors:  V Kapur; M W Majesky; L L Li; R A Black; J M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

7.  M-related protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes.

Authors:  A Podbielski; N Schnitzler; P Beyhs; M D Boyle
Journal:  Mol Microbiol       Date:  1996-02       Impact factor: 3.501

8.  Introduction of the emm6 gene into an emm-deleted strain of Streptococcus pyogenes restores its ability to resist phagocytosis.

Authors:  J Perez-Casal; M G Caparon; J R Scott
Journal:  Res Microbiol       Date:  1992 Jul-Aug       Impact factor: 3.992

9.  C5a peptidase alters clearance and trafficking of group A streptococci by infected mice.

Authors:  Y Ji; L McLandsborough; A Kondagunta; P P Cleary
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

10.  A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin.

Authors:  V Kapur; S Topouzis; M W Majesky; L L Li; M R Hamrick; R J Hamill; J M Patti; J M Musser
Journal:  Microb Pathog       Date:  1993-11       Impact factor: 3.738

View more
  58 in total

1.  Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins.

Authors:  M Collin; A Olsén
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

Review 2.  Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes.

Authors:  Mattias Collin; Arne Olsén
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

3.  An amino-terminal signal peptide of Vfr protein negatively influences RopB-dependent SpeB expression and attenuates virulence in Streptococcus pyogenes.

Authors:  Samuel A Shelburne; Randall J Olsen; Nishanth Makthal; Nicholas G Brown; Pranoti Sahasrabhojane; Ebru M Watkins; Timothy Palzkill; James M Musser; Muthiah Kumaraswami
Journal:  Mol Microbiol       Date:  2011-11-21       Impact factor: 3.501

4.  Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64.

Authors:  R Raeder; E Harokopakis; S Hollingshead; M D Boyle
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  Identification and characterization of bicistronic speB and prsA gene expression in the group A Streptococcus.

Authors:  Yongsheng Ma; Amy E Bryant; Dan B Salmi; Susan M Hayes-Schroer; Eric McIndoo; Michael J Aldape; Dennis L Stevens
Journal:  J Bacteriol       Date:  2006-09-01       Impact factor: 3.490

Review 6.  A decade of molecular pathogenomic analysis of group A Streptococcus.

Authors:  James M Musser; Samuel A Shelburne
Journal:  J Clin Invest       Date:  2009-09       Impact factor: 14.808

7.  Streptococcal pyrogenic exotoxin B induces apoptosis and reduces phagocytic activity in U937 cells.

Authors:  C F Kuo; J J Wu; P J Tsai; F J Kao; H Y Lei; M T Lin; Y S Lin
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

8.  A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes.

Authors:  W R Lyon; C M Gibson; M G Caparon
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

9.  Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes.

Authors:  Jovanka M Voyich; Daniel E Sturdevant; Kevin R Braughton; Scott D Kobayashi; Benfang Lei; Kimmo Virtaneva; David W Dorward; James M Musser; Frank R DeLeo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

10.  SpeB of Streptococcus pyogenes differentially modulates antibacterial and receptor activating properties of human chemokines.

Authors:  Arne Egesten; Anders I Olin; Helena M Linge; Manisha Yadav; Matthias Mörgelin; Anna Karlsson; Mattias Collin
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.